DEA Temporarily Extends COVID-19 Flexibilities for Controlled Substance Prescriptions via Telemedicine While Evaluating Permanent Rule Changes - klgates.com
DEA extends COVID-19 telemedicine flexibilities for controlled substance prescriptions until the later of the end of the PHE or permanent rule changes, maintaining current allowances for remote prescribing without an in-person visit.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 30, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense controlled substances prescribed via telemedicine. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No immediate deadline; extension is in effect until the later of the end of the PHE or publication of permanent rules.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The DEA temporarily extended the COVID-19 telemedicine flexibilities, allowing controlled substance prescriptions to continue without an initial in-person medical evaluation until permanent rules are finalized or the PHE ends.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense controlled substances prescribed via telemedicine.
What you must do
Continue current telemedicine prescribing practices as allowed; monitor for permanent rule changes.
Deadline
No immediate deadline; extension is in effect until the later of the end of the PHE or publication of permanent rules.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Illinois PBM Law to Limit Steering, Other Plan Design Features in 2026 - ogletree.com
- Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court - kff.org
- US-CONGRESS BILLS-119hr9693ih: Patients First Act of 2026
- ERISA doesn't preempt Arkansas PBM reporting law, court rules - BenefitsPRO
- New year brings new electronic prescribing law - mcafeetaft.com